Humanetics Corporation to Highlight Medical Countermeasure at Investor Conference Ready to Announce with Confidence?
Minneapolis, Minnesota--(Newsfile Corp. - May 14, 2026) - Humanetics Corporation, an advanced clinical-stage specialty pharmaceutical company pioneering novel prophylactic medical countermeasures for warfighters, first responders, and others at risk of radiation exposure from nuclear incidents, industrial accidents, or cancer radiation therapy, today announced that Dana B. Shinbaum, the Company's Director, Business Development, will be presenting at the LD Micro Invitational XVI, Luxe Sunset Blvd Hotel, Los Angeles on May 18, 2026, 12:00pm PDT. The presentation will focus on BYOGRAYZ™ (BIO 300), an orally administered prophylactic Medical Countermeasure (MCM) for warfighters, designed to prevent toxicities caused by exposure to radiation, with potential dual-use application in multiple clinical indications.
Information about the event, including links to the webcast, can be found at this link.
Location:
Luxe Sunset Blvd Hotel
11461 Sunset Blvd
Los Angeles, CA 90049
Humanetics will be meeting with potential investors and partners before, during, and after the event. Interested parties may contact the Company:
Dana B. Shinbaum
Director, Business Development
dshinbaum@humaneticscorp.com
(US) 480-440-9700
About Humanetics Corporation
Humanetics Corporation is an advanced clinical-stage specialty pharmaceutical company engaged in the accelerated discovery, development, and commercialization of proprietary drugs in markets with urgent and unmet needs with a focus on radiation modulators for oncology and medical countermeasures. For more information, visit www.humaneticscorp.com.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/297381
Source: LD Micro
Analyst, journalist, or company stakeholder? Sign up to receive news releases by email for LD Micro or all companies in the Publishing / Informational Services industry.
Humanetics Corporation to Highlight Medical Countermeasure at Investor Conference
2026-05-14 8:00 AM EDT
mPath Therapeutics to Present at LD Micro Invitational XVI Alongside Keynote Speaker Lamar Odom
2026-05-13 4:40 PM EDT
Interlink Electronics, Inc. to Present at the LD Micro Invitational XVI
2026-05-13 9:00 AM EDT
Feb 12, 2026
For European investor relations firms, global reach is no longer a nice to have. It is an expectation. For Interaction Partners, a Swiss based provider of investor relations software and financial communications services, the challenge was not capability. It was geography. By partnering with TMX Newsfile, they found a way to bridge the gap between European markets and North American press release distribution through a shared approach to execution. “Switzerland and Canada really do seem to...
Economy, Business and Finance
Computing and Information Technology
Consumer Goods
Electronic Commerce
Publishing / Informational Services